ScholarIQanswers from OpenAlex

TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy

PaperCitations, authors & open-access status

TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy have?

ScholarIQcitation count

TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy has 32 citations in the OpenAlex counts ScholarIQ stores.

When was TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy published?

ScholarIQyear

TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy has 2024 year in the ScholarIQ index.

What is the open-access status of TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy?

ScholarIQoa status

TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy has hybrid oa status in the ScholarIQ index.

What is the DOI of TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy?

ScholarIQdoi

The DOI for TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy is on the source record.

What is the PMID of TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy?

ScholarIQpmid

The PMID for TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy is on the source record.

What is the OpenAlex record for TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy?

ScholarIQopenalex

The OpenAlex for TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial